The Market for In Vitro Diagnostic (IVD) Tests in Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela and Other Nations)

$5,000.00 – $10,000.00

SKU: 23-051 Categories: , , Tags: , , , , , , , , , , , , , , , , , , , , , , Pages: 195

Description

This report, The Market for In Vitro Diagnostic (IVD) Tests in Latin America, focuses on the market for reagents and instruments in the most important countries of the region. Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela are singled out for a deeper level of analysis; the countries of Bolivia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Nicaragua, Panama, Paraguay, and Uruguay were also considered to provide a complete overview of the region.

Combined, these countries represent a population of 646 million; a large potential IVD market audience.  Brazil and Mexico represent the two largest countries in terms of population, accounting for more than half of LATAM total population.  For this reason, these two countries have been the focus for many IVD suppliers in recent years.  However, as economic conditions strengthen in other countries and demand increases for quality health services, there are additional opportunities in countries such as Chile, Colombia and Peru.

Segments Analyzed

The segments under analysis include reagents, consumables, calibrators and controls of the following subsegments:

  • Clinical Chemistry: substrates, enzymes, homogeneous immunoassays, proteins, ISE (non POC), HBA1c (non POC).
  • Critical Care: blood gas and electrolytes, including rapid tests.
  • Urinalysis: manual, semi-automated and automated. Include urine strips, urine sediment reagents and disposables in automated systems.
  • Microbiology Immunoassays: HIV, Hepatitis, ToRCH, COVID-19, Influenza, Syphilis, and other infectious diseases agents. Excludes tests processed in blood banks.
  • Immunoassay (non-microbiology): hormones, tumor markers, bone markers, oncology markers, autoimmunity, allergy, anemia, neonatal tests, prenatal tests, interleukins, PCT. Also includes non-POC drugs of abuse testing and therapeutic drug monitoring.
  • Cardiac Markers: non POC cardiac markers (Troponine, BNP, CK-MB, Homocystein, Myoglobin).
  • Blood Banking: immunotyping and infectious diseases screening.
  • Microbiology: manual and automated tests, culture media (to be prepared or ready to use), latex tests, transport media, blood culture, sensitivity discs, Gram and other stains, MTB culture, Mycoplasma, Ureaplasma.
  • Molecular Microbiology: HIV, Hepatitis, STDs (CT, NG, HPV), MRSA, MTB, Sepsis, EBV, CMV, Respiratory Panel, COVID-19 and other infectious diseases agents. Also includes multiplex NAT.
  • POC: all POC tests for allergy, autoimmune, cardiology, coagulation, fecal occult blood, fertility, HbA1c, lipid, pregnancy, toxicology, TSH. Excludes POC glucose testing and infectious disease testing.
  • POC Infectious Disease Testing: COVID-19, HIV, influenza, STDs, streptococci, and other. Includes home collected test kits.
  • POC Glucose Testing: diabetes glucose monitoring strips.
  • Primary Staining Histology: PAP, HE and other primary stains.
  • Advanced Staining Histology: IHC, ISH, FISH, primary and secondary antibodies.
  • Hematology: manual, semi-automated and automated (CBC and 5 Diff).
  • Coagulation: PT, APTT, coagulation factors, Fibrinogen, FDP, Lupus Anticoagulant and other analytes from the thrombosis and hemostasis pathway.
  • Flow Cytometry: manual, semi-automated and automated flow cytometry for CD4/CD8 (AIDS), leukemia, lymphoma, infectious diseases, autoimmune disorders. Includes follow-up to abnormal cell count testing.
  • Other Molecular: hemato-oncology, hereditary diseases, hemostasis and hematology diseases, transplant and other molecular testing not defined elsewhere. Excludes coagulation factors.
Research Methodology

Interviews with IVD market participants, public and private laboratory operations managers, government representatives and health professionals were the primary source of information.   Primary research focused on the seven countries highlighted in this report, Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela.  Other LATAM countries’ markets were estimated using mostly secondary research – which consisted of medical journals, healthcare data from government agencies, import/export databases (specifically focusing on HS Codes 90 and 98), registered business databases (specifically focusing on NAICS code 325413) and other information.  In all cases, information was compared to the previous IVD Latin America editions, which includes VA Consultora y Asociados data as well as to secondary information from other sources.  As secondary source of information statistics from public tenders, as well as output data provided by the main funding entities and reagents, inputs and instrument imports made by labs were used.

Depending on the source, there are differences in the information about the countries of the region. Quality data reporting varies by country and is a primary weakness in the region.  Some countries report quality data while others have low quality, incomplete information or the information is manipulated in some way.  Kalorama Information has reviewed data from multiple sources, both country-reported and global databases, to generate the most reliable, current and complete information available.

Table of Contents

Chapter 1: Executive Summary

Overview

Table 1-1: Population and GDP in Seven Leading IVD Latin American Countries (Argentina, Brazil, Chile, Colombia, Mexico, Peru, & Venezuela), 2022

Size of the Market and Growth

Figure 1-1: IVD Market in Latin America, 2022-2027

Latin American IVD Market by Country

Figure 1-2: Latin America IVD Market by Country (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela, other LATAM), 2022 (%)

Growth of IVD Market in Latin America by Country, CAGR 2022 to 2027

Figure 1-3: Average Growth of Latin America IVD Market by Country (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela, other LATAM), CAGR 2022 to 2027 (%)

IVD Company Market Share in Latin America

Figure 1-4: IVD Market Share in Latin America, by Company (Abbott, Agilent, Becton Dickson, bioMérieux, Bio-Rad, Danaher, Diagnostica Stago, DiaSorin, Grifols Hologic, LifeScan, Mindray, Qiagen, QuidelOrtho, Roche, Siemens, Sysmex, Thermo Fisher, Werfen, Wiener, Others), 2022

Segments Definition

Research Methodology

 

Chapter 2: Argentina

Overview and Demographics

Table 2-1: Key Facts, Argentina (Population and Growth, Aging Population and Growth, Urbanization Rate, Life Expectancy, Median Age, Elderly Dependency Ratio)

Economy and Health Funding

History of the Healthcare System of Argentina

Table 2-2: Health System and Indicators, Argentina (Physician Density, Hospital Bed Density, Hospital Total, Diabetes Prevalence, Diabetes Count, Obesity Prevalence, HIV Prevalence, Deaths, Crude Death Rate)

Health Expenditures as Percentage of GDP

Table 2-3: Economic Profile, Argentina (GDP nominal, GDP PPP, GDP Growth, Health Spending, Inflation Rate, Poverty Rate), 2022

COVID-19 Testing Market in Argentina

IVD Market Analysis – Argentina

Total Market Size

Table 2-4: Argentinian IVD Market by Sector, 2022-2027 (General Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, POC Infectious Disease, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular) ($US thousands)

IVD Market in Argentina by Segment

Figure 2-1: Argentinian IVD Market Distribution by Sector (General Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, POC Infectious Disease, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2022 (%)

Figure 2-2: Average Growth of IVD Markets in Argentina, CAGR 2022 to 2027 (%)

Clinical Chemistry Market in Argentina

Figure 2-3: Clinical Chemistry Market in Argentina by Segment (general chemistries, critical care, urinalysis), Estimate and Forecast, 2022-2027 ($US thousands)

Figure 2-4: Clinical Chemistry Market in Argentina, Market Participant (Abbott, Danaher, Roche, Siemens, Others) Share, 2022 (%)

General Chemistry Market in Argentina

Critical Care- Rapid Market in Argentina

Urinalysis Market in Argentina

Immunoassay Market in Argentina

Figure 2-5: Immunoassay Market in Argentina by Segment (infectious disease, cardiac markers, other diseases, blood bank screening), Estimate and Forecast, 2022-2027 ($US thousands)

Figure 2-6: Immunoassay Market in Argentina, Market Participant Share (Abbott, Roche, Siemens, Others) 2022 (%)

Microbiology Immunoassay Market in Argentina

Cardiac Markers (non-POC) Market in Argentina

Non-Microbiology Immunoassay Market in Argentina

Blood Banking Market in Argentina

Microbiology Market in Argentina

Figure 2-7: Microbiology Market in Argentina by Segment (ID/AST, molecular, nucleic acid tests), Estimate and Forecast, 2022-2027 ($US thousands)

Figure 2-8: Microbiology Market in Argentina, Market Participant Share (bioMérieux, Roche, Siemens, Others), 2022 (%)

ID/AST Market in Argentina

Molecular Microbiology and Nucleic Acid Test Market in Argentina

POC Market in Argentina

Figure 2-9: POC Market in Argentina by Segment (glucose, infectious disease, other), Estimate and Forecast, 2022-2027 ($US thousands)

Figure 2-10: POC Market in Argentina, Market Participant Share (Abbott, LifeScan, Roche, Others), 2022 (%)

POC Glucose Testing Market in Argentina

Histology Market in Argentina

Figure 2-11: Histology Market in Argentina, by Segment (primary, advanced) Estimate and Forecast, 2022-2027 ($US thousands)

Hematology Market in Argentina

Coagulation Market in Argentina

Flow Cytometry Market in Argentina

Non-infectious Disease Molecular Market in Argentina

Market Participants

Abbott Diagnostics

Becton Dickinson Argentina

Bioars SA

Biodiagnostico SA

bioMérieux

Bio-Rad Laboratories, Inc.

Gematec SRL

Grifols Argentina SA

LifeScan Argentina

Rochem Biocare Argentina S.A.

Productos Roche SA

Siemens Healthcare S.A. Argentina

Wiener Lab

WM Argentina

Market Share

Table 2-5: IVD Market Share by Company, Argentina (Abbott Laboratories Argentina SA, Becton Dickinson Argentina SRL, BioMérieux Argentina SA, Danaher, Diagnostica Stago, LifeScan, Productos Roche SA, QuidelOrtho, Siemens Sociedad Anonima, Werfen/WM Argentina SA/Instrumentation Laboratory, Wiener Laboratorios, Others), 2022 (%)

Figure 2-12: IVD Market Argentina, Market Participant Share (Abbott Laboratories Argentina SA, Becton Dickinson Argentina SRL, BioMérieux Argentina SA, Danaher, Diagnostica Stago, LifeScan, Productos Roche SA, QuidelOrtho, Siemens Sociedad Anonima, Werfen/WM Argentina SA/Instrumentation Laboratory, Wiener Laboratorios, Others), 2022 (%)

 

Chapter 3: Brazil

Overview and Demographics

Table 3-1: Key Facts, Brazil (Population and Growth, Aging Population and Growth, Urbanization Rate, Life Expectancy, Median Age, Elderly Dependency Ratio)

Economy and Health Funding

History of the Healthcare System of Brazil

Medical Facilities

Table 3-2: Health System and Indicators, Brazil (Physician Density, Hospital Bed Density, Hospital Total, Length of Hospital Stay, Diabetes Prevalence, Diabetes Count, Obesity Prevalence, HIV Prevalence, Deaths, Crude Death Rate)

Health Expenditures as Percentage of GDP

Table 3-3: Economic Profile, Brazil (GDP nominal, GDP PPP, GDP Growth, Health Spending, Inflation Rate, Poverty Rate), 2022

COVID-19 Testing Market in Brazil

IVD Market Analysis – Brazil

Total Market Size

Table 3-4: Brazil IVD Market by Sector, (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, POC Infectious Disease, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2022-2027 (in $US thousands)

IVD Market in Brazil by Segment

Figure 3-1: Brazil IVD Market Distribution by Sector (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, POC Infectious Disease, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2022 (%)

Figure 3-2: Average Growth of IVD Markets in Brazil (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, POC Infectious Disease, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), CAGR 2022 to 2027 (%)

Clinical Chemistry Market in Brazil

Figure 3-3: Clinical Chemistry Market in Brazil by Segment (general chemistries, critical care, urinalysis), Estimate and Forecast, 2022-2027 ($US thousands)

Figure 3-4: Clinical Chemistry Market in Brazil, Market Participant Share (Abbott, Danaher, Roche, Siemens, Others) 2022 (%)

General Chemistry Market in Brazil

Critical Care Market in Brazil

Urinalysis Market in Brazil

Immunoassay Market in Brazil

Figure 3-5: Immunoassay Market in Brazil by Segment (infectious disease, cardiac markers, other diseases, blood bank screening), Estimate and Forecast, 2022-2027 ($US thousands)

Figure 3-6: Immunoassay Market in Brazil, Market Participant Share (bioMérieux, Roche, Siemens, Others), 2022 (%)

Microbiology Immunoassay Market in Brazil

Immunoassay (non-Microbiology) Market in Brazil

Cardiac Marker (non-POC) Market in Brazil

Blood Banking Market in Brazil

Microbiology Market in Brazil

Figure 3-7: Microbiology Market in Brazil by Segment (ID/AST, molecular, nucleic acid tests), Estimate and Forecast, 2022-2027 $US thousands

Figure 3-8: Microbiology Market in Brazil, Market Participant Share (bioMérieux, Roche, Siemens, Others), 2022 (%)

Molecular Microbiology Market in Brazil

POC Market in Brazil

Figure 3-9: POC Market in Brazil by Segment (glucose, infectious disease, other), Estimate and Forecast, 2022-2027 $US thousands

Figure 3-10: POC Market in Brazil, Market Participant Share (Abbott, Roche, and Others), 2022 (%)

Histology Market in Brazil

Figure 3-11: Histology Market in Brazil, by Segment (primary, advanced) Estimate and Forecast, 2022-2027 $US thousands

Hematology Market in Brazil

Coagulation Market in Brazil

Flow Cytometry Market in Brazil

Non-infectious Disease Molecular Market in Brazil

Market Participants

Abbott Laboratorios do Brazil Ltda.

Becton Dickinson

bioMérieux Brazil SA

Bio-Rad Laboratorios Brasil Ltda

Danaher – Beckman Coulter

DiaSorin Ltda.

HORIBA ABX

QuidelOrtho

LifeScan Brazil

Qiagen

Roche

Siemens Healthcare Diagnostics SA

Sysmex do Brasil Industria e Comercio Ltda.

WAMA Diagnostica

Wiener Laboratories SAIC/Labinbraz

Market Share

Table 3-5: IVD Market Share by Company (Abbott, Becton Dickinson, bioMérieux, Bio-Rad, Danaher [Beckman Coulter, Radiometer, Cephid], DiaSorin, Labinbraz-Wiener, LifeScan, Roche, Siemens, Sysmex, Thermo Fisher), Brazil, 2022

Figure 3-12: IVD Market Brazil, Market Participant Share (Abbott, Becton Dickinson, bioMérieux, Bio-Rad, Danaher [Beckman Coulter, Radiometer, Cephid], DiaSorin, Labinbraz-Wiener, LifeScan, Roche, Siemens, Sysmex, Thermo Fisher), 2022 (%)

 

Chapter 4: Chile

Overview and Demographics

Table 4-1: Key Facts, Chile (Population and Growth, Aging Population and Growth, Urbanization Rate, Life Expectancy, Median Age, Elderly Dependency Ratio)

Economy and Health Funding

History of the Healthcare System of Chile

Table 4-2: Health System and Indicators, Chile (Physician Density, Hospital Bed Density, Hospital Total, Length of Hospital Stay, Diabetes Prevalence, Diabetes Count, Obesity Prevalence, HIV Prevalence, Deaths, Crude Death Rate)

Health Expenditures as Percentage of GDP

Table 4-3: Economic Profile, Chile (GDP nominal, GDP PPP, GDP Growth, Health Spending, Inflation Rate, Poverty Rate), 2022

COVID-19 Testing Market in Chile

IVD Market Analysis – Chile

Total Market Size

Table 4-4: Chile IVD Market by Sector (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, POC Infectious Disease, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2022-2027

Figure 4-1: Chile IVD Market Distribution by Sector (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, POC Infectious Disease, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2022 (%)

Figure 4-2: Average Growth of IVD Markets in Chile (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, POC Infectious Disease, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), CAGR 2022 to 2027 (%)

Clinical Chemistry Market in Chile

Figure 4-3: Clinical Chemistry Market in Chile by Segment (general chemistries, critical care, urinalysis), Estimate and Forecast, 2022-2027 ($US thousands)

Figure 4-4: Clinical Chemistry Market in Chile, Market Participant Share (Abbott, Mindray, QuidelOrtho, Roche, Siemens, Others), 2022 (%)

Urinalysis Market in Chile

Immunoassay Market in Chile

Figure 4-5: Immunoassay Market in Chile by Segment (infectious disease, cardiac markers, other diseases, blood bank screening), Estimate and Forecast, 2022-2027 ($US thousands)

Figure 4-6: Immunoassay Market in Chile, Market Participant Share (Abbott, Beckman Coulter, bioMérieux, QuidelOrtho, Roche, Siemens, Others), 2022 (%)

Microbiology Immunoassay Market in Chile

Immunoassay (non-Microbiology) Market in Chile

Cardiac Marker (non-POC) Market in Chile

Blood Banking Market in Chile

Microbiology Market in Chile

Figure 4-7: Microbiology Market in Chile by Segment (ID/AST, molecular, nucleic acid tests), Estimate and Forecast, 2022-2027 ($US thousands)

Figure 4-8: Microbiology Market in Chile, Market Participant Share (Becton Dickinson, bioMérieux, Diasorin, Roche, Others), 2022 (%)

Molecular Microbiology and NAT Market in Chile

POC Market in Chile

Figure 4-9: POC Market in Chile by Segment (glucose, infectious disease, other), Estimate and Forecast, 2022-2027 ($US thousands)

Glucose Testing Market in Chile

Histology Market in Chile

Figure 4-10: Histology Market in Chile, by Segment (primary, advanced) Estimate and Forecast, 2022-2027 ($US thousands)

Hematology Market in Chile

Coagulation Market in Chile

Flow Cytometry Market in Chile

Non-infectious Disease Molecular Market in Chile

Market Participants

Abbott Diagnostics

BD Chile

bioMérieux Chile SA

Galenica

Grifols Chile S.A.

GrupoBios Chile

LifeScan Chile

Roche

Siemens Healthcare Medical Equipment SPA

Tecnigen S.A.

Market Share

Table 4-5: IVD Market Share by Company (Abbott, Agilent, Beckman Coulter – Danaher, Becton Dickinson, bioMérieux Chile, DiaSorin, Grifols Chile S.A., LifeScan, Mindray, QuidelOrtho, Roche, Siemens S.A., Others), Chile, 2022

Figure 4-11: IVD Market Chile, Market Participant Share (Abbott, Agilent, Beckman Coulter – Danaher, Becton Dickinson, bioMérieux Chile, DiaSorin, Grifols Chile S.A., LifeScan, Mindray, QuidelOrtho, Roche, Siemens S.A., Others), 2022 (%)

 

Chapter 5: Colombia

Overview and Demographics

Table 5-1: Key Facts, Colombia (Population and Growth, Aging Population and Growth, Urbanization Rate, Life Expectancy, Median Age, Elderly Dependency Ratio)

Economy and Health Funding

History of the Healthcare System of Colombia

Table 5-2: Health System and Indicators, Colombia (Physician Density, Hospital Bed Density, Hospital Total, Length of Hospital Stay, Diabetes Prevalence, Diabetes Count, Obesity Prevalence, HIV Prevalence, Deaths, Crude Death Rate)

Health Expenditures as Percentage of GDP

Table 5-3: Economic Profile, Colombia (GDP nominal, GDP PPP, GDP Growth, Health Spending, Inflation Rate, Poverty Rate), 2022

COVID-19 Testing Market in Colombia

IVD Market Analysis – Colombia

Total Market Size

Table 5-4: Colombia IVD Market by Sector, (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, POC Infectious Disease, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2022-2027 (in $US thousands)

IVD Market in Colombia by Segment

Figure 5-1: Colombia IVD Market Distribution by Sector (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, POC Infectious Disease, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2022 (%)

Figure 5-2: Average Growth of IVD Markets in Colombia (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, POC Infectious Disease, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), CAGR 2022 to 2027 (%)

Clinical Chemistry Market in Colombia

Figure 5-3: Clinical Chemistry Market in Colombia by Segment (general chemistries, critical care, urinalysis), Estimate and Forecast, 2022-2027 ($US thousands)

Figure 5-4: Clinical Chemistry Market in Colombia, Market Participant Share (Abbott, Beckman Coulter, Roche, Werfen-IL, Others), 2022 (%)

Immunoassay Market in Colombia

Figure 5-5: Immunoassay Market in Colombia by Segment (infectious disease, cardiac markers, other diseases, blood bank screening), Estimate and Forecast, 2022-2027 ($US thousands)

Figure 5-6: Immunoassay Market in Colombia, Market Participant Share (Abbott, Bio-Rad Laboratories, Roche, Others), 2022 (%)

Microbiology Market in Colombia

Figure 5-7: Microbiology Market in Colombia by Segment (ID/AST, molecular, nucleic acid tests), Estimate and Forecast, 2022-2027 ($US thousands)

Figure 5-8: Microbiology Market in Colombia, Market Participant Share (Abbott, Becton Dickinson, bioMérieux, Others), 2022 (%)

Molecular Microbiology and NAT Market in Colombia

POC Market in Colombia

Figure 5-9: POC Market in Colombia by Segment (glucose, infectious disease, other), Estimate and Forecast, 2022-2027 ($US thousands)

Histology Market in Colombia

Figure 5-10: Histology Market in Colombia, by Segment (primary, advanced) Estimate and Forecast, 2022-2027 ($US thousands)

Hematology Market in Colombia

Coagulation Market in Colombia

Flow Cytometry Market in Colombia

Non-infectious Disease Molecular Market in Colombia

Market Participants

Abbott de Colombia SA

Annar Diagnóstica Import SAS

Becton Dickinson de Colombia Ltda

bioMérieux Colombia SAS

Biolore Ltda

Bio-Rad Laboratories, Inc.

Labcare de Colombia Ltda

Laboratorio DAI de Colombia

Quimiolab SAS

Roche Diagnostics

Rochem Biocare

Siemens SA

Werfen Colombia

Market Share

Table 5-5: IVD Market Share by Company (Abbott Laboratories De Colombia S.A., Becton Dickinson De Colombia Ltda., bioMérieux Colombia Ltda., Bio-Rad, Danaher – Beckman Coulter, Diagnostica Stago, Grifols, Productos Roche S.A., Siemens S.A., Werfen – IL, Others), Colombia, 2022 (%)

Figure 5-11: IVD Market Colombia, Market Participant Share (Abbott Laboratories De Colombia S.A., Becton Dickinson De Colombia Ltda., bioMérieux Colombia Ltda., Bio-Rad, Danaher – Beckman Coulter, Diagnostica Stago, Grifols, Productos Roche S.A., Siemens S.A., Werfen – IL, Others), 2022 (%)

 

Chapter 6: Mexico

Overview and Demographics

Table 6-1: Key Facts, Mexico (Population and Growth, Aging Population and Growth, Urbanization Rate, Life Expectancy, Median Age, Elderly Dependency Ratio)

Economy and Health Funding

History of the Healthcare System of Mexico

Table 6-2: Health System and Indicators, Mexico (Physician Density, Hospital Bed Density, Hospital Total, Length of Hospital Stay, Diabetes Prevalence, Diabetes Count, Obesity Prevalence, HIV Prevalence, Deaths, Crude Death Rate)

Health Expenditures as Percentage of GDP

Table 6-3: Economic Profile, Mexico (GDP nominal, GDP PPP, GDP Growth, Health Spending, Inflation Rate, Poverty Rate), 2022

COVID-19 Testing Market  in Mexico

IVD Market Analysis – Mexico

Total Market Size

Table 6-4: Mexico IVD Market Distribution by Sector (Clinical Chemistry, Critical Care – Rapid, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, POC Infectious Disease, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2022-2027 (in $US thousands)

IVD Market in Mexico by Segment

Figure 6-1: Mexico IVD Market Distribution by Sector (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, POC Infectious Disease, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2022 (%)

Figure 6-2: Average Growth of IVD Markets in Mexico (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, POC Infectious Disease, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), CAGR 2022 to 2027 (%)

Clinical Chemistry Market in Mexico

Figure 6-3: Clinical Chemistry Market in Mexico by Segment (general chemistries, critical care, urinalysis), Estimate and Forecast, 2022-2027 ($US thousands)

Figure 6-4: Clinical Chemistry Market in Mexico, Market Participant Share (Abbott, Danaher, Roche, Siemens, Others), 2022 (%)

Immunoassay Market in Mexico

Figure 6-5: Immunoassay Market in Mexico by Segment (infectious disease, cardiac markers, other diseases, blood bank screening), Estimate and Forecast, 2022-2027 ($US thousands)

Figure 6-6: Immunoassay Market in Mexico, Market Participant Share, 2022 (%)

Immunoassay Microbiology Market in Mexico

Immunoassay (non-Microbiology) Market in Mexico

Microbiology Market in Mexico

Figure 6-7: Microbiology Market in Mexico by Segment (ID/AST, molecular, nucleic acid tests), Estimate and Forecast, 2022-2027 ($US thousands)

Figure 6-8: Microbiology Market in Mexico, Market Participant Share (bioMérieux, Roche, Siemens, Others) 2022 (%)

POC Market in Mexico

Histology Market in Mexico

Figure 6-9: Histology Market in Mexico, by Segment (primary, advanced) Estimate and Forecast, 2022-2027 ($US thousands)

Hematology Market in Mexico

Coagulation Market in Mexico

Flow Cytometry Market in Mexico

Non-infectious Disease Molecular Market in Mexico

Market Participants

Abbott Diagnostics

Becton Dickinson

bioMérieux

Bio-Rad SA

Danaher

DiaSorin S.p.A.

LifeScan

Roche

Siemens Healthcare Diagnostics S. de RL de CV

Thermo Fisher Scientific

Market Share

Table 6-5: IVD Market Share by Company (Abbott, Becton Dickinson, bioMérieux, Danaher, DiaSorin, LifeScan, Qiagen, Roche, Siemens, Thermo Fisher, Werfen, Others), Mexico, 2022

Figure 6-10: IVD Market Mexico, Market Participant Share (Abbott, Becton Dickinson, bioMérieux, Danaher, DiaSorin, LifeScan, Qiagen, Roche, Siemens, Thermo Fisher, Werfen, Others), 2022 (%)

 

Chapter 7: Peru

Overview and Demographics

Table 7-1: Key Facts, Peru (Population and Growth, Aging Population and Growth, Urbanization Rate, Life Expectancy, Median Age, Elderly Dependency Ratio)

Economy and Health Funding

History of the Healthcare System of Peru

Table 7-2: Health System and Indicators, Peru (Physician Density, Hospital Bed Density, Hospital Total, Length of Hospital Stay, Diabetes Prevalence, Diabetes Count, Obesity Prevalence, HIV Prevalence, Deaths, Crude Death Rate)

Health Expenditures as Percentage of GDP

Table 7-3: Economic Profile, Peru (GDP nominal, GDP PPP, GDP Growth, Health Spending, Inflation Rate, Poverty Rate), 2022

COVID-19 Testing Market in Peru

IVD Market Analysis – Peru

Total Market Size

Table 7-4: Peru IVD Market by Sector, (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, POC Infectious Disease, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2022-2027 (in $US thousands)

IVD Market in Peru by Segment

Figure 7-1: Peru IVD Market Distribution by Sector (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, POC Infectious Disease, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2022 (%)

Figure 7-2: Average Growth of IVD Markets in Peru (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, POC Infectious Disease, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), CAGR 2022 to 2027 (%)

Clinical Chemistry Market in Peru

Figure 7-3: Clinical Chemistry Market in Peru by Segment (general chemistries, critical care, urinalysis), Estimate and Forecast, 2022-2027 ($US thousands)

Figure 7-4: Clinical Chemistry Market in Peru, Market Participant Share (Danaher, Mindray, Roche, Siemens, Wiener Lab, Others), 2022 (%)

Immunoassay Market in Peru

Figure 7-5: Immunoassay Market in Peru by Segment (infectious disease, cardiac markers, other diseases, blood bank screening), Estimate and Forecast, 2022-2027 ($US thousands)

Figure 7-6: Immunoassay Market in Peru, Market Participant Share (Abbott, Beckman Coulter, Roche, Siemens, Others), 2022 (%)

Immunoassay Microbiology Market in Peru

Immunoassay (non-Microbiology) Market in Peru

Blood Banking Market in Peru

Microbiology Market in Peru

Figure 7-7: Microbiology Market in Peru by Segment (ID/AST, molecular, nucleic acid tests), Estimate and Forecast, 2022-2027 ($US thousands)

Figure 7-8: Microbiology Market in Peru, Market Participant Share (Becton Dickinson, bioMérieux, Roche, Others), 2022 (%)

Molecular/NAT Microbiology Market in Peru

POC Market in Peru

Figure 7-9: POC Market in Peru by Segment (glucose, infectious disease, other), Estimate and Forecast, 2022-2027 ($US thousands)

Histology Market in Peru

Figure 7-10: Histology Market in Peru, by Segment (primary, advanced) Estimate and Forecast, 2022-2027 ($US thousands)

Hematology Market in Peru

Coagulation Market in Peru

Flow Cytometry Market in Peru

Non-infectious Disease Molecular Market in Peru

Market Participants

Abbott Laboratories SA

Albis SA

Beckman Coulter Peru – Danaher

Becton Dickinson del Uruguay SA Peru Branch

Belomed SRL

Jampar Multiplest Internacional

Labin Peru

Roche Diagnostics

Rochem Biocare

Siemens Healthcare SAC

Market Share

Table 7-5: IVD Market Share by Company, Peru, 2022

Figure 7-11: IVD Market Peru, Market Participant Share 2022 (%)

 

Chapter 8: Venezuela

Overview and Demographics

Table 8-1: Key Facts, Venezuela (Population and Growth, Aging Population and Growth, Urbanization Rate, Life Expectancy, Median Age, Elderly Dependency Ratio)

Economy and Health Funding

History of the Healthcare System of Venezuela

Table 8-2: Health System and Indicators, Venezuela (Physician Density, Hospital Bed Density, Hospital Total, Diabetes Prevalence, Diabetes Count, Obesity Prevalence, HIV Prevalence, Cancer Incidence, Deaths, Crude Death Rate)

Health Expenditures as Percentage of GDP

Table 8-3: Economic Profile, Venezuela (GDP nominal, GDP PPP, GDP Growth, Health Spending, Inflation Rate, Poverty Rate), 2022

COVID-19  Testing Market in Venezuela

IVD Market Analysis – Venezuela

Total Market Size

Table 8-4: Venezuela IVD Market Distribution by Sector (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, POC Infectious Disease, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2022-2027 (in $US thousands)

IVD Market in Venezuela by Segment

Figure 8-1: Venezuela IVD Market Distribution by Sector (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, POC Infectious Disease, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), 2022 (%)

Figure 8-2: Average Growth of IVD Markets in Venezuela (Clinical Chemistry, Critical Care, Urinalysis, Immunoassays Micro, Immunoassays Non-Micro, Blood Banking, Microbiology, Molecular Microbiology, Nucleic Acid Tests, POC Glucose Testing, POC Infectious Disease, Other POC, Primary Histology, Advanced Histology, Hematology, Coagulation, Flow Cytometry, Other Molecular), CAGR 2022 to 2027 (%)

Clinical Chemistry Market in Venezuela

Figure 8-3: Clinical Chemistry Market in Venezuela by Segment (general chemistries, critical care, urinalysis), Estimate and Forecast, 2022-2027 ($US thousands)

Immunoassay Market in Venezuela

Figure 8-4: Immunoassay Market in Venezuela by Segment (infectious disease, cardiac markers, other diseases, blood bank screening), Estimate and Forecast, 2022-2027 ($US thousands)

Microbiology Market in Venezuela

Figure 8-5: Microbiology Market in Venezuela by Segment (ID/AST, molecular, nucleic acid tests), Estimate and Forecast, 2022-2027 ($US thousands)

POC Market in Venezuela

Histology Market in Venezuela

Hematology Market in Venezuela

Coagulation Market in Venezuela

Flow Cytometry Market in Venezuela

Non-infectious Disease Molecular Market in Venezuela

Market Participants

Abbott Laboratories, CA

Productos Roche SA – Roche Diagnostica

Danaher

Loginca

Siemens

Market Share

Table 8-5: IVD Market Share by Company (Abbott, Becton Dickinson, bioMérieux, Danaher, DiaSorin, QuidelOrtho, Roche, Siemens, Thermo Fisher, Werfen, Others), Venezuela, 2022

Figure 8-6: IVD Market Venezuela, Market Participant Share 2022 (%)

 

Chapter 9: Latin America IVD Market Summary

Demographic Overview

Table 9-1: Demographics in Select Latin American Countries (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dom. Rep., Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay, Venezuela), 2022

Figure 9-1: Population Comparison, Select Latin American Countries (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dom. Rep., Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay, Venezuela), 2022 (population in millions)

Figure 9-2: Population Growth, Select Latin American Countries (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dom. Rep., Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay, Venezuela), 2022-2032 (%)

Figure 9-3: Aging Population as a % of Total Population, Select Latin American Countries (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dom. Rep., Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay, Venezuela), 2022 (%)

Figure 9-4: Life Expectancy at Birth by LATAM Country (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dom. Rep., Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay, Venezuela) (Average 76 Years), 2022 (years)

Table 9-2: Leading Causes of Death by Country (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), LATAM 2022

Brief Economic Overview

GDP in the Latin American Region

Table 9-3: GDP in Select Latin American Countries (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dom. Rep., Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay, Venezuela), 2022

Figure 9-5: GDP Comparison, Select Latin American Countries (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dom. Rep., Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay, Venezuela), 2022 (billions USD)

Figure 9-6: GDP per Capita, Select Latin American Countries (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dom. Rep., Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay, Venezuela), 2022 (USD)

Health Expenditure in Latin America

Figure 9-7: Health Spending as a Percent of GDP by LATAM Country (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dom. Rep., Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay, Venezuela), 2022

The IVD Market in Latin America

Table 9-4: IVD in Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela, Other LATAM) 2022-2027 in $US thousands

Figure 9-8: IVD in Latin America by Country (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela, Rest of LATAM), 2022-2027

Figure 9-9: IVD in Latin America, Distribution of Sales by Select Country (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela, Rest of LATAM), 2022

IVD Market Participation in Latin America

Abbott

Danaher

Becton Dickinson

bioMérieux

Roche

Siemens

Figure 9-10: IVD Market Share by Participant, LATAM, 2022

Conclusions, Recommendations and Market Attractiveness

Table 9-5: IVD Attractiveness by LATAM Country (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), 2022-2027

Figure 9-11: IVD Market Attractiveness by LATAM County (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), 2022-2027

 

Related products

Physician Office In Vitro Diagnostic (IVD) Test Markets The World Market for Veterinary Diagnostics, 6th Edition